Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005203947
Tue, 25.10.2022
BRAIN Biotech AG
BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides
Zwingenberg, Germany and Charlottesville, VA, USA, 25 October 2022 – BRAIN Biotech AG, a leading European industrial biotechnology specialist, and rare sugars expert Bonumose, announced today that they have reached initial project milestones as part of the [ … ]
Tue, 25.10.2022
BRAIN Biotech AG
BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides
Zwingenberg, Germany and Charlottesville, VA, USA, 25 October 2022 – BRAIN Biotech AG, a leading European industrial biotechnology specialist, and rare sugars expert Bonumose, announced today that they have reached initial project milestones as part of the [ … ]
Tue, 27.09.2022
BRAIN Biotech AG
Lukas Linnig stepping down as CFO. Michael Schneiders to become new CFO of BRAIN Biotech AG as of October 1st, 2022
Lukas Linnig and Dr. Michael Krohn to jointly lead Akribion Genomics activities
Akribion Genomics established as new brand for the proprietary BRAIN genome editing platform technology
Zwingenberg, September 27, 2022 – BRAIN Biot [ … ]
Tue, 27.09.2022
BRAIN Biotech AG
Lukas Linnig stepping down as CFO. Michael Schneiders to become new CFO of BRAIN Biotech AG as of October 1st, 2022
Lukas Linnig and Dr. Michael Krohn to jointly lead Akribion Genomics activities
Akribion Genomics established as new brand for the proprietary BRAIN genome editing platform technology
Zwingenberg, September 27, 2022 – BRAIN Biot [ … ]
Mon, 26.09.2022
BRAIN Biotech AG
BRAIN Biotech AG further focusses business activities
Transaction closed on September 26, 2022
URI group expands its network into European production
Zwingenberg, September 26, 2022 – BRAIN Biotech AG has announced the sale of its subsidiary L.A. Schmitt GmbH, Ludwigsstadt, to a company of the URI group, Seoul, Korea. The transaction has close [ … ]
Mon, 26.09.2022
BRAIN Biotech AG
BRAIN Biotech AG further focusses business activities
Transaction closed on September 26, 2022
URI group expands its network into European production
Zwingenberg, September 26, 2022 – BRAIN Biotech AG has announced the sale of its subsidiary L.A. Schmitt GmbH, Ludwigsstadt, to a company of the URI group, Seoul, Korea. The transaction has close [ … ]
Mon, 29.08.2022
BRAIN Biotech AG
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Positive topline growth trend confirmed by 29% expansion in Q3
9M Operating cash flow improved significantly from last year
On track to reach full financial year 2021/22 guidance
Zwingenberg, Germany, August 29th, 2022 – BRAIN Biotech AG today published its 9M 2021 [ … ]
Mon, 29.08.2022
BRAIN Biotech AG
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Positive topline growth trend confirmed by 29% expansion in Q3
9M Operating cash flow improved significantly from last year
On track to reach full financial year 2021/22 guidance
Zwingenberg, Germany, August 29th, 2022 – BRAIN Biotech AG today published its 9M 2021 [ … ]
Mon, 20.06.2022
BRAIN Biotech AG
BRAIN Biotech publishes first ESG and Sustainability Report
Zwingenberg, June 20, 2022 – BRAIN Biotech AG has published its first ESG and sustainability report. The company, which already directly addresses at least five UN Sustainable Development Goals (SDGs) with its products and solutions, sees the accelerated development towards sustainable bu [ … ]
Mon, 30.05.2022
BRAIN Biotech AG
Prof. Dr. Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasonsZwingenberg, 30.05.2022 – Professor Dr. Bernhard Hauer has informed the Chairman of the Supervisory Board of BRAIN Biotech AG that he wishes to resign from his position as a member of the Supervisory Board of BRAIN Biotech AG in the near future for personal re [ … ]